Cita APA

F, C., F, I., AM, M., P, D., S, L., T, V., . . . VM, V. (2021). Does Empagliflozin Modulate Leukocyte-Endothelium Interactions, Oxidative Stress, and Inflammation in Type 2 Diabetes?

Citación estilo Chicago

F, Canet, et al. Does Empagliflozin Modulate Leukocyte-Endothelium Interactions, Oxidative Stress, and Inflammation in Type 2 Diabetes? 2021.

Cita MLA

F, Canet, et al. Does Empagliflozin Modulate Leukocyte-Endothelium Interactions, Oxidative Stress, and Inflammation in Type 2 Diabetes? 2021.